Related Experiment Video
Updated: Aug 18, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary
Alessandro Spirito1, Ashutosh Sharma1, Davide Cao2
1Zena and Michael A. Wiener Cardiovascular Institute Icahn School of Medicine, Mount Sinai, New York, New York.
Insights
A new score accurately identifies patients at high risk of death after percutaneous coronary intervention (PCI). This validated tool aids in stratifying patients undergoing PCI for better risk assessment and outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Health Outcomes Research
Background:
- A universal definition for identifying high-risk patients undergoing percutaneous coronary intervention (PCI) is currently lacking.
- Risk stratification after PCI is crucial for optimizing patient management and improving outcomes.
Purpose of the Study:
- To validate a recently developed risk score for identifying patients at increased risk of all-cause death following PCI.
- To assess the score's predictive value for major adverse cardiovascular events and major bleeding.
Main Methods:
- A large PCI registry was utilized, including consecutive patients undergoing PCI (excluding ST-elevation myocardial infarction or cardiogenic shock).
- A risk score was calculated based on age >80 years, dialysis, left ventricular ejection fraction <30%, and multivessel PCI.
- Patients were stratified into low (score 0), intermediate (score 2-3), and high (score ≥4) risk groups.
Main Results:
- The validated score demonstrated good predictive value for all-cause death at 1 year (AUC 0.70).
- High-risk patients (score ≥4) had a ninefold higher hazard for all-cause death compared to low-risk patients.
- The risk of major adverse cardiovascular events and major bleeding increased consistently across risk strata.
Conclusions:
- The validated 4-variable score effectively predicts 1-year all-cause mortality in patients undergoing PCI for stable ischemic heart disease or non-ST-elevation acute coronary syndrome.
- This risk score can aid clinicians in identifying high-risk individuals, facilitating personalized treatment strategies.
- The score also shows utility in predicting secondary outcomes like MACE and major bleeding post-PCI.
Abstract:
A universal definition to identify patients at higher risk of complications after percutaneous coronary intervention (PCI) is lacking. We aimed to validate a recently developed score to identify patients at increased risk of all-cause death after PCI. All consecutive patients from a large PCI registry not presenting with ST-elevation myocardial infarction or cardiogenic shock were included. Each patient was assigned a score obtained by summing the points associated with the following variables: age >80 years (3 points), dialysis (6 points), left ventricular ejection fraction <30% (2 points), and multivessel PCI (2 points). Patients were stratified in 3 groups: low risk (score 0), intermediate risk (score 2 to 3), or high risk (score ≥4). The primary outcome was all-cause death, and the secondary outcomes were major adverse cardiovascular events and major bleeding. Events were assessed at 1 year after PCI. Between January 2014 and December 2019, 12,689 patients underwent PCI. Compared with the 9,884 patients at low risk, those at intermediate and high risk had a fourfold (hazard ratio 3.99, 95% confidence interval 2.95 to 5.38) and ninefold (hazard ratio 9.55, 95% confidence interval 6.89 to 13.2) higher hazard for all-cause death at 1 year, respectively. The score had a good predictive value for all-cause death at 1 year (area under the curve 0.70). The risk of major adverse cardiovascular events and major bleeding increased consistently from the low- to the high-risk group. In conclusion, in patients who underwent PCI for stable ischemic heart disease or non-ST-elevation acute coronary syndrome, a score based on 4 variables well predicted the risk of all-cause death at 1 year.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization IV: Nursing Management